all-trans-retinol/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Decreases melanoma incidence
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Findingreplicated ×1“Relative to non-use, current (HR 0.60, 95% CI: 0.41–0.89) but not former (HR 0.90, 95% CI: 0.57–1.43) use of individual retinol supplements at baseline was associated with a decreased risk of melanoma.”
Quoted verbatim from Association of vitamin A and carotenoid intake with melanoma risk in a large prospective cohort.. - Study
- cohort
- Population
- Men and women aged 50-76 years in the VITAL cohort, western Washington; current users of individual retinol supplements at baseline compared with non-users; incident melanoma by SEER linkage to 2007
Effect 0.6 hazard ratio, 95% CI 0.41 to 0.89
Association of vitamin A and carotenoid intake with melanoma risk in a large prospective cohort.2012PMID:22377763Permalink
Keep reading
- Everything the graph holds on all-trans-retinol
- Every compound studied against Melanoma incidence
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M5KX2BN3AGGFC7330EFB8XWR